Treatment of rabbit intervertebral disc degeneration with co-transfection by adeno-associated virus-mediated SOX9 and osteogenic protein-1 double genes in vivo

Evans C: Potential biologic therapies for the intervertebral disc. J Bone Joint Surg Am. 88(Suppl 2): 95–98. 2006. View Article : Google Scholar

Wehling P, Schulitz KP, Robbins PD, Evans CH and Reinecke JA: Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine (Phila Pa 1976). 22:1092–1097. 1997. View Article : Google Scholar : PubMed/NCBI

Sai JM, Hu YG and Wang DC: Constructing adeno-associated virus-TGFbeta3 and comparing its biological effect on proteoglycan synthesis in dedifferentiated nucleus pulpous cells with adenovirus-TGFbeta1. Chin Med Sci J. 22:113–118. 2007.

Wallach C, Sobajima S, Watanabe Y, et al: Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine (Phila Pa 1976). 28:2331–2337. 2003. View Article : Google Scholar : PubMed/NCBI

Lohr F, Huang Q, Hu K, Dewhirst MW and Li CY: Systemic vector leakage and transgene expression by intratmorally injected recombinant adenovirus vectors. Clin Cancer Res. 7:3625–3628. 2001.PubMed/NCBI

Xi YM, Dong YF, Wang ZJ, Liu Y, Diao ZZ and Hu YG: Co-transfection of adeno-associated virus-mediated human vascular endothelial growth factor 165 and transforming growth factor-β1 into annulus fibrosus cells of rabbit degenerative intervertebral discs. Genet Mol Res. Feb 28–2013.(Epub ahead of print).

Wallach CJ, Gilbertson LG and Kang JD: Gene therapy applications for intervertebral disc degeneration. Spine (Phila Pa 1976). 28:93–98. 2003. View Article : Google Scholar : PubMed/NCBI

Xi Y, Kong J, Liu Y, et al: Minimally invasive induction of an early lumbar disc degeneration model in rhesus monkeys. Spine (Phila Pa 1976). 38:E579–E586. 2013. View Article : Google Scholar : PubMed/NCBI

Nishida K, Suzuki T, Kakutani K, et al: Gene therapy approach for disc degeneration and associated spinal disorders. Eur Spine J. 17(Suppl 4): 459–466. 2008. View Article : Google Scholar : PubMed/NCBI

Nishida K, Kang JD, Gilbertson LG, et al: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta1 encoding gene. Spine (Phila Pa 1976). 24:2419–2425. 1999.

Haro H, Grawford HC, Fingleton B, et al: Matrix metalloprotemase-3-dependent generation of a macrophage chemoattractant in model of herniated disc resorption. J Clin Incest. 105:133–141. 2000. View Article : Google Scholar : PubMed/NCBI

Osada R, Ohshima H, Ishihara H, et al: Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J Orthop Res. 14:690–699. 1996. View Article : Google Scholar : PubMed/NCBI

Moon S, Nishirla K, Gilbertson LG, et al: Biologic response of human interverterbral disc cell to gene therapy cocktail. Spine (Phila Pa 1976). 33:1850–1855. 2008. View Article : Google Scholar : PubMed/NCBI

Imai Y, Miyamoto K, An HS, Thonar EJ, Andersson GB and Masuda K: Recombinant human osteogenic protein-1 upregulates proteoglycan metabolism of human anulus fibrosus and nucleus pulposus cells. Spine (Phila Pa 1976). 32:1303–1309. 2007. View Article : Google Scholar : PubMed/NCBI

Takegami K, Thonar EJ, An HS, Kamada H and Masuda K: Osteogentic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine (Phila Pa 1976). 27:1318–1325. 2002. View Article : Google Scholar : PubMed/NCBI

Masuda K, Imai Y, Okuma M, et al: Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976). 31:742–754. 2006. View Article : Google Scholar : PubMed/NCBI

Zhang Y, An HS, Song S, et al: Growth factor osteogenic protein-1: differing effects on cells fron three distinct zones in the bovine intervertebral disc. Am J Phys Med Rehabil. 83:515–521. 2004. View Article : Google Scholar : PubMed/NCBI

Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA and Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral disc. Mol Pathol. 55:91–97. 2002. View Article : Google Scholar : PubMed/NCBI

Paul R, Haydon RC, Cheng HW, et al: Potential use of S0X9 gene therapy for intcrvcrtcbral degenerative disc disease. Spine (Phila Pa 1976). 28:755–763. 2003. View Article : Google Scholar

Gruber HE, Norton HJ, Ingram JA and Hanley EN Jr: The S0 transcription factor in the human disc: decreased immunolocalization with ageand disc degeneration. Spine (Phila Pa 1976). 30:625–630. 2005. View Article : Google Scholar : PubMed/NCBI

Lefebvre V, Huang W, Harley VR, Goodfellow PN and de Crombrugghe B: Sox9 is a potent activator of the chondrocyte-specific enhancer of the proalphal(II) collagen gene. Mol Cell Biol. 17:2336–2346. 1997.PubMed/NCBI

Shintani N and Hunziker EB: Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue. Arthritis Rheum. 56:1869–1879. 2007. View Article : Google Scholar